[Prevalence and clinical characteristics of familial hypercholesterolemia among Chinese patients undergoing coronary angiography due to angina-like chest pain]

Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Feb 24;46(2):104-108. doi: 10.3760/cma.j.issn.0253-3758.2018.02.007.
[Article in Chinese]

Abstract

Objectives: To investigate the prevalence rate and clinical characteristics of familial hypercholesterolemia (FH) in Chinese patients undergoing coronary angiography due to angina-like chest pain. Methods: From March 2011 to December 2016, a total of 9 908 consecutive patients undergoing coronary angiography in Fuwai Hospital due to angina-like chest pain were enrolled. The age of enrolled patients was (56.6±11.1) years old, and 6 782 cases (68.4%) were male. The patients were divided into two groups: FH group (n=271) and non-FH group (n=9 637) according to the Dutch Lipid Clinic Network diagnostic criteria. A retrospective analyze was performed on the baseline features between the two groups including lipids levels, coronary artery disease (CAD) characteristics, and lipids-lowering treatments. Results: In the total cohort, the prevalence of definite/probable FH was 2.7% (271/9 908). The incidence of premature coronary artery disease (PCAD) (women < 60 years old, or men < 55 years old) was higher in patients with FH than that in patients without FH (70.2%(201/271) vs. 44.5% (4 287/9 637); χ(2)=93.738, P<0.001). Patients with FH had higher level of TC and LDL-C when compared with patients without FH ((6.74±2.48) mmol/L vs. (4.15±1.10) mmol/L; (4.53±2.39) mmol/L vs. (2.52±0.97) mmol/L; t=19.403, 22.233, P<0.001, respectively). Additionally, 84.9% (230/271) of FH patients were treated with statin at different intensities, but none of them achieved the LDL-C<2.6 mmol/L. Conclusions: Chinese patients with familial hypercholesterolemia not only showed a high presence of PCAD and higher lipids levels, but also exhibited a low rate of achievement of low-density lipoprotein cholesterol targets despite statin therapy. Our results thus highlight the importance of early diagnosis and intensive treatment of FH patients.

目的: 分析心血管专科医院因胸痛就诊的患者中家族性高胆固醇血症(FH)的检出情况及临床特征。 方法: 连续入选了2011年3月至2016年12月因胸痛就诊于阜外医院血脂中心行选择性冠状动脉造影检查的9 908例患者,平均年龄为(56.6±11.1)岁,其中6 782例(68.4%)为男性。按照荷兰临床脂质网络标准,将入选者分为FH组(271例)和非FH组(9 637例),回顾性分析比较两组患者间血脂水平、冠心病患病情况及调脂治疗情况的差异。 结果: 通过荷兰临床脂质网络标准,入选的患者中2.7%(271/9 908)被诊断为FH。FH组中早发冠心病(指女性<60岁,男性<55岁)的比例占70.2%(201/271),非FH组中早发冠心病比例占44.5%(4 287/9 637),其差异有统计学意义(χ(2)=93.738,P<0.001)。FH组患者的总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)水平高于非FH组[TC:(6.74±2.48)mmol/L比(4.15±1.10)mmol/L;LDL-C:(4.53±2.39)mmol/L比(2.52±0.97)mmol/L; t值分别为19.403、22.233,P均<0.001];此外,FH组中84.9%(230/271)的患者经过不同强度他汀药物调脂治疗,但是无1例患者LDL-C水平低于2.6 mmol/L。 结论: 中国人群FH患者检出率较低,其早发冠心病比例高,血脂水平高,但调脂治疗达标率低。因此,对FH患者需早期诊断及强化治疗。.

Keywords: Chest pain; Dyslipidemias; Familial hypercholesterolemia; Premature coronary artery disease.

MeSH terms

  • Aged
  • Chest Pain
  • China / epidemiology
  • Cholesterol, LDL
  • Coronary Angiography
  • Coronary Artery Disease / pathology*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hyperlipoproteinemia Type II / epidemiology
  • Hyperlipoproteinemia Type II / pathology*
  • Incidence
  • Male
  • Middle Aged
  • Prevalence
  • Retrospective Studies

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors